Global Dendritic Tumor Cell Cancer Vaccine Market 9.2% CAGR 2034
According to a new report from Intel Market Research, the global Dendritic Cell and Tumor Cell Cancer Vaccine market was valued at USD 556 million in 2024 and is projected to grow from USD 608 million in 2025 to USD 1,015 million by 2034, exhibiting a robust CAGR of 9.2% during the forecast period (2025–2034). This growth is propelled by the rising global cancer burden, rapid advancements...
0 Kommentare 0 Geteilt 75 Ansichten 0 Bewertungen
Nguza _ Social Earning Marketplace. https://nguza.com